88427-81-0

Upstream product

• 4786-20-3 crotononitrile 
• 86798-58-5 α-<4-(1H-imidazol-1-yl)phenyl>-4-morpholineacetonitrile 
• 97150-78-2 2-<4-(1H-imidazol-1-yl)phenyl>-3-methyl-2-(4-morpholinyl)pentanedinitrile 
• 10040-98-9 1-(4-formylphenyl)-1H-imidazole 
• 88427-89-8 4-(1H-imidazol-1-yl)-β-methyl-γ-oxobenzenebutanenitrile 

Downstream Products

• 86798-76-7 6-<4-(1H-imidazol-1-yl)phenyl>-5-methyl-3(2H)-pyridazinone 
• 366-77-8 4-(4-fluorophenyl)-4-oxopropionic acid 
• 84243-57-2 4-(1H-imidazol-1-yl)-γ-oxobenzenebutanoic acid 
• 84243-58-3 imazodan 
• 86798-59-6 4,5-dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-5-methyl-3(2H)-pyridazinone 
• 462-06-6 fluorobenzene 

Relevant academic research and scientific papers

Cardiotonic Agents. 2. Synthesis and Structure-Activity Relationships of 4,5-Dihydro-6--3(2H)-pyridazinones: A New Class of Positive Inotropic Agents

A series of 4,5-dihydro-6--3(2H)-pyridazinones and related compounds were synthesized and evaluated for positive inotropic activity.Most members of this series produced dose-related increases in myocardial contractility that we

Method of treating high blood pressure using 6-[4-(1-imidazolyl)-phenyl]-5-methyl-3-oxo-tetrahydropyridazines

The present invention relates to new 6-[Imidazolyl-phenyl]-5-methyl-3-oxo-tetrahydropyridazines of the general formula I STR1 as well as their acid addition salts, methods for their use, and pharmaceutical preparations containing them.